Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY, USA.
Department of Neurosurgery, Medical University Vienna, Vienna, Austria.
Nat Biomed Eng. 2024 Jun;8(6):672-688. doi: 10.1038/s41551-024-01217-3. Epub 2024 Jul 10.
The most widely used fluorophore in glioma-resection surgery, 5-aminolevulinic acid (5-ALA), is thought to cause the selective accumulation of fluorescent protoporphyrin IX (PpIX) in tumour cells. Here we show that the clinical detection of PpIX can be improved via a microscope that performs paired stimulated Raman histology and two-photon excitation fluorescence microscopy (TPEF). We validated the technique in fresh tumour specimens from 115 patients with high-grade gliomas across four medical institutions. We found a weak negative correlation between tissue cellularity and the fluorescence intensity of PpIX across all imaged specimens. Semi-supervised clustering of the TPEF images revealed five distinct patterns of PpIX fluorescence, and spatial transcriptomic analyses of the imaged tissue showed that myeloid cells predominate in areas where PpIX accumulates in the intracellular space. Further analysis of external spatially resolved metabolomics, transcriptomics and RNA-sequencing datasets from glioblastoma specimens confirmed that myeloid cells preferentially accumulate and metabolize PpIX. Our findings question 5-ALA-induced fluorescence in glioma cells and show how 5-ALA and TPEF imaging can provide a window into the immune microenvironment of gliomas.
5-氨基酮戊酸(5-ALA)是胶质瘤切除术中最常用的荧光团,被认为能使肿瘤细胞内荧光原卟啉 IX(PpIX)选择性积累。在这里,我们展示了一种通过同时进行配对受激发射拉曼组织学和双光子激发荧光显微镜(TPEF)的显微镜来提高 PpIX 临床检测的方法。我们在四家医疗机构的 115 名高级别胶质瘤患者的新鲜肿瘤标本中验证了该技术。我们发现,所有成像标本的组织细胞密度与 PpIX 荧光强度之间存在弱负相关。对 TPEF 图像进行半监督聚类,揭示了 PpIX 荧光的五种不同模式,对成像组织的空间转录组学分析表明,髓样细胞在 PpIX 在细胞内空间积累的区域占优势。对Glioblastoma 标本的外部空间分辨代谢组学、转录组学和 RNA-seq 数据集的进一步分析证实,髓样细胞优先积累和代谢 PpIX。我们的研究结果对 5-ALA 诱导的胶质瘤细胞荧光提出了质疑,并展示了 5-ALA 和 TPEF 成像如何为胶质瘤的免疫微环境提供一个窗口。
Acta Neurochir (Wien). 2016-10
Npj Imaging. 2025-6-23
Cancers (Basel). 2025-4-15
Br J Cancer. 2025-3
Nat Rev Clin Oncol. 2021-11
Nat Biotechnol. 2021-11